{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:58:57Z","timestamp":1793051937439,"version":"4.5.0"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.2967\/jnumed.119.238923","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T21:42:54Z","timestamp":1595022174000},"page":"332-337","source":"Crossref","is-referenced-by-count":107,"title":["Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium"],"prefix":"10.2967","volume":"62","author":[{"given":"Sally F.","family":"Barrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben G.J.C.","family":"Zwezerijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrica C.W.","family":"de Vet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn W.","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. George","family":"Mikhaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coreline N.","family":"Burggraaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakoba J.","family":"Eertink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto S.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e M.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"2021030407200936000_62.3.332.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2822-7"},{"key":"2021030407200936000_62.3.332.2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"J Clin Oncol."},{"key":"2021030407200936000_62.3.332.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-616474"},{"key":"2021030407200936000_62.3.332.4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hon.2437_18","article-title":"Can baseline PET-CT features predict outcomes in advanced Hodgkin lymphoma? A prospective evaluation of UK patients in the RATHL trial (CRUK\/07\/033)","volume":"35","author":"Pike","year":"2017","journal-title":"Hematol Oncol."},{"key":"2021030407200936000_62.3.332.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-788877"},{"key":"2021030407200936000_62.3.332.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193946"},{"key":"2021030407200936000_62.3.332.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-826958"},{"key":"2021030407200936000_62.3.332.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.01.010"},{"key":"2021030407200936000_62.3.332.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.180406"},{"key":"2021030407200936000_62.3.332.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140830"},{"key":"2021030407200936000_62.3.332.11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00259-018-3953-z","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","volume":"45","author":"Ilyas","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200936000_62.3.332.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3315-7"},{"key":"2021030407200936000_62.3.332.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-773838"},{"key":"2021030407200936000_62.3.332.14","first-page":"T020(0067)","article-title":"Baseline PET features as predictors of outcome in advanced HL: a prospective evaluation of UK patients in the RATHL trial (CRUK\/07\/033)","volume":"2","author":"Guezennec","year":"2018","journal-title":"Hemasphere."},{"key":"2021030407200936000_62.3.332.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-635169"},{"key":"2021030407200936000_62.3.332.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2705-y"},{"key":"2021030407200936000_62.3.332.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(03)00270-6"},{"key":"2021030407200936000_62.3.332.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0363-4"},{"key":"2021030407200936000_62.3.332.19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00259-017-3865-3","article-title":"Tumour functional sphericity from PET images: prognostic value in NSCLC and impact of delineation method","volume":"45","author":"Hatt","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200936000_62.3.332.20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2967\/jnumed.119.227249","article-title":"Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden","volume":"60","author":"Barrington","year":"2019","journal-title":"J Nucl Med."},{"key":"2021030407200936000_62.3.332.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"2021030407200936000_62.3.332.22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","article-title":"EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies","volume":"44","author":"Aide","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200936000_62.3.332.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.148056"},{"key":"2021030407200936000_62.3.332.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-744292"},{"key":"2021030407200936000_62.3.332.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-795476"},{"key":"2021030407200936000_62.3.332.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.3747"},{"issue":"suppl 1","key":"2021030407200936000_62.3.332.27","first-page":"1753","article-title":"Quantitative oncology molecular analysis suite: ACCURATE [abstract]","volume":"59","author":"Boellaard","year":"2018","journal-title":"J Nucl Med."},{"key":"2021030407200936000_62.3.332.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.173831"},{"key":"2021030407200936000_62.3.332.29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s11307-020-01474-z","article-title":"Optimizing workflows for fast and reliable metabolic tumor volume measurements in diffuse large B cell lymphoma","volume":"22","author":"Burggraaff","year":"2020","journal-title":"Mol Imaging Biol."},{"key":"2021030407200936000_62.3.332.30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00259-015-3239-7","article-title":"Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation","volume":"43","author":"Schaefer","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200936000_62.3.332.31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.media.2017.12.007","article-title":"The first MICCAI challenge on PET tumor segmentation","volume":"44","author":"Hatt","year":"2018","journal-title":"Med Image Anal."},{"key":"2021030407200936000_62.3.332.32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"2021030407200936000_62.3.332.33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00259-018-3953-z","article-title":"Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma","volume":"45","author":"Ilyas","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.238923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T10:25:48Z","timestamp":1614853548000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.238923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.2967\/jnumed.119.238923"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.238923","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}